Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions
Univercells has raised $43.3M in total funding. The most recent round was Series D. The last funding was announced in October 2022.
Univercells's investors include Bill & Melinda Gates Foundation, Korea Investment Partners, Farallon Capital Management, Kohlberg Kravis Roberts & Co., Adjuvant Capital.
Univercells is headquartered in Gosselies, Belgium.
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions
Univercells is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Univercells — Funding & Investors." VCBacked, October 17, 2022, https://www.vcbacked.co/company/univercells. Accessed September 15, 2026.
VCBacked. (2022). Univercells — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/univercells
{{cite web |title=Univercells — Funding & Investors |url=https://www.vcbacked.co/company/univercells |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated